Limited near term gains for Syngene International stock in pharma space
Sharp re-rating has turned the stock into the most expensive in the pharma space04-01-2021
04-01-2021
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached the schedule of the upcoming investor calls.17-12-2020
Syngene International Ltd - 539268 - Reporting Under SEBI (Prevention Of Insider Trading) Regulations, 2015
Intimation of Violation under Insider Trading Code by a Designated Employee. In terms of SEBI circular SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020, please find attached as Annexure A, the report by the Company for violation on Code of Conduct for Prevention of Insider Trading under SEBI (Prevention of Insider Trading) Regulations, 2015. We would like to submit that the reported deviation is not material in relation to the total paid up equity share capital of the Company. You are requested to take this intimation on record.16-12-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached the schedule of the upcoming investor calls.13-12-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Meetings with Analysts/Institutional Investor09-12-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached the schedule of the upcoming investor calls.30-11-2020
Syngene International Ltd - 539268 - Reporting Under SEBI (Prevention Of Insider Trading) Regulations, 2015
Please find attached the intimation of violation under Insider Trading Code by an Designated Person27-11-2020
Syngene International Ltd - 539268 - Submission Of Disclosure On Related Parties Transactions
Pursuant to Regulation 23(9) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions on Consolidated basis for the half-year ended September 30, 2020, drawn in accordance with the applicable Accounting Standards. The above-mentioned disclosure will also be available on website of the Company www.syngeneintl.com. Kindly take the above information on record.19-11-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed the press release titled 'Syngene and Deerfield Discovery and Development (3DC) sign 5-year strategic collaboration'. The press release will also be available on website of the Company www.syngeneintl.com. This is for your information and record.19-11-2020
Syngene, 3DC ink pact for advancing therapeutic discovery projects
Syngene International on Thursday said it has signed an agreement with Deerfield Discovery and Development Corporation (3DC)to collaborate for five years to advance therapeutic discovery projects.19-11-2020